Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $65.5900 (-16.35%) ($65.0550 - $70.6700) on Tue. Jun. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 22 | Latest Price | $65.5900(-16.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -3.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(50%) VYM(50%) IVE(49%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -1.135% in a week (0% probabilities). VIXM(-36%) VXX(-15%) TLT(-14%) IFRA(-11%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 0 () | Intraday Trend | -6.9% | | | |
|
Resistance Level | $77.14 | 5 Day Moving Average | $75.75(-13.41%) | 10 Day Moving Average | $77.06(-14.88%) | 20 Day Moving Average | $77.14(-14.97%) | To recent high | -21.9% | To recent low | 0% | Market Cap | $115.719b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |